02005 石四藥集團
按盤價 
2.870 +0.030 (+1.056%) | 日期 | 股東名稱 | 披露原因 | 買入／賣出涉及 的股份數目 |
每股平均價 | 持有權益的 股份數目 |
佔已發行 股本(%) |
| 11/06/2025 | UBS Group AG | 1201(L) | -3,192,000(L) | HKD2.979(L) | 204,947,540(L) | 6.98 |
| 03/06/2025 | UBS Group AG | 1201(L) | -7,726,000(L) | HKD2.970(L) | 228,790,696(L) | 7.77 |
| 19/05/2025 | 曲繼廣 | 1113(L) | +500,000(L) | HKD2.930(L) | 1,168,982,000(L) | 39.61 |
| 19/05/2025 | China Pharmaceutical Company Limited | 1710(L) | +500,000(L) | HKD2.930(L) | 877,764,000(L) | 29.74 |
| 16/05/2025 | China Pharmaceutical Company Limited | 1710(L) | +1,776,000(L) | HKD2.886(L) | 877,264,000(L) | 29.72 |
| 16/05/2025 | 曲繼廣 | 1113(L) | +1,776,000(L) | HKD2.886(L) | 1,168,482,000(L) | 39.59 |
| 29/04/2025 | China Pharmaceutical Company Limited | 1710(L) | +1,000,000(L) | HKD2.955(L) | 875,488,000(L) | 29.64 |
| 29/04/2025 | 曲繼廣 | 1113(L) | +1,000,000(L) | HKD2.955(L) | 1,166,706,000(L) | 39.50 |
| 16/04/2025 | 曲繼廣 | 1113(L) | +1,400,000(L) | HKD2.954(L) | 1,165,706,000(L) | 39.46 |
| 16/04/2025 | China Pharmaceutical Company Limited | 1710(L) | +1,400,000(L) | HKD2.954(L) | 874,488,000(L) | 29.60 |
| 15/04/2025 | 曲繼廣 | 1101(L) | +580,000(L) | HKD3.032(L) | 1,164,306,000(L) | 39.41 |
| 11/04/2025 | China Pharmaceutical Company Limited | 1710(L) | +800,000(L) | HKD3.011(L) | 873,088,000(L) | 29.55 |
| 11/04/2025 | 曲繼廣 | 1113(L) | +800,000(L) | HKD3.011(L) | 1,163,726,000(L) | 39.39 |
| 09/04/2025 | 曲繼廣 | 1113(L) | +300,000(L) | HKD3.021(L) | 1,162,926,000(L) | 39.37 |
| 09/04/2025 | China Pharmaceutical Company Limited | 1710(L) | +300,000(L) | HKD3.021(L) | 872,288,000(L) | 29.53 |
| 07/04/2025 | China Pharmaceutical Company Limited | 1710(L) | +6,000,000(L) | HKD3.006(L) | 871,988,000(L) | 29.52 |
| 07/04/2025 | 曲繼廣 | 1113(L) | +6,000,000(L) | HKD3.006(L) | 1,162,626,000(L) | 39.36 |
| 03/04/2025 | China Pharmaceutical Company Limited | 1710(L) | +3,000,000(L) | HKD3.355(L) | 865,988,000(L) | 29.31 |
| 03/04/2025 | 曲繼廣 | 1113(L) | +3,000,000(L) | HKD3.355(L) | 1,156,626,000(L) | 39.15 |
| 01/04/2025 | 曲繼廣 | 1113(L) | +3,000,000(L) | HKD3.363(L) | 1,152,226,000(L) | 39.01 |
| 01/04/2025 | China Pharmaceutical Company Limited | 1710(L) | +3,000,000(L) | HKD3.363(L) | 862,988,000(L) | 29.22 |
| 01/04/2025 | 曲繼廣 | 1101(L) | +1,400,000(L) | HKD3.374(L) | 1,153,626,000(L) | 39.05 |
| 31/03/2025 | China Pharmaceutical Company Limited | 1710(L) | +2,800,000(L) | HKD3.191(L) | 859,988,000(L) | 29.11 |
| 31/03/2025 | 曲繼廣 | 1113(L) | +2,800,000(L) | HKD3.191(L) | 1,149,226,000(L) | 38.90 |
| 21/02/2025 | UBS Group AG | 1201(L) | -372,000(L) | HKD3.244(L) | 265,496,063(L) | 8.98 |
| 20/02/2025 | UBS Group AG | 1101(L) | +198,000(L) | HKD3.335(L) | 265,867,466(L) | 9.00 |
| 18/02/2025 | UBS Group AG | 1201(L) | -448,204(L) | HKD3.238(L) | 265,697,464(L) | 8.99 |
| 08/01/2025 | 曲繼廣 | 1113(L) | +500,000(L) | HKD3.263(L) | 1,146,426,000(L) | 38.76 |
| 08/01/2025 | China Pharmaceutical Company Limited | 1710(L) | +500,000(L) | HKD3.263(L) | 857,188,000(L) | 28.98 |
| 07/01/2025 | 曲繼廣 | 1113(L) | +600,000(L) | HKD3.337(L) | 1,145,926,000(L) | 38.74 |
| 07/01/2025 | China Pharmaceutical Company Limited | 1710(L) | +600,000(L) | HKD3.337(L) | 856,688,000(L) | 28.96 |
| 06/01/2025 | 曲繼廣 | 1113(L) | +600,000(L) | HKD3.388(L) | 1,145,326,000(L) | 38.72 |
| 06/01/2025 | China Pharmaceutical Company Limited | 1710(L) | +600,000(L) | HKD3.388(L) | 856,088,000(L) | 28.94 |
| 03/01/2025 | 曲繼廣 | 1113(L) | +660,000(L) | HKD3.372(L) | 1,144,726,000(L) | 38.70 |
| 03/01/2025 | China Pharmaceutical Company Limited | 1710(L) | +660,000(L) | HKD3.372(L) | 855,488,000(L) | 28.92 |
| 26/11/2024 | 曲繼廣 | 1101(L) | +1,300,000(L) | HKD3.490(L) | 1,144,066,000(L) | 38.68 |
| 20/11/2024 | 曲繼廣 | 1101(L) | +400,000(L) | HKD3.880(L) | 1,142,766,000(L) | 38.63 |
| 19/11/2024 | 曲繼廣 | 1101(L) | +900,000(L) | HKD3.772(L) | 1,142,366,000(L) | 38.62 |
| 15/11/2024 | China Pharmaceutical Company Limited | 1710(L) | +1,000,000(L) | HKD3.807(L) | 854,828,000(L) | 28.90 |
| 15/11/2024 | 曲繼廣 | 1113(L) | +1,000,000(L) | HKD3.807(L) | 1,141,466,000(L) | 38.59 |
| 1 2 3 | ||||||
| 備註： | (L) - 長倉：包括 (1) 持有股份；(2) 透過持有、沽出或發行金融合約，有權或有責任購買相關股份。 |
| (S) - 短倉：包括 (1) 借入股份；(2) 透過持有、沽出或發行金融合約，有權或有責任沽出相關股份。 | |
| (P) - 可供借出的股份 | |
| 即時報價更新時間為 11/07/2025 18:00 | |
| 港股即時基本市場行情由香港交易所提供; 香港交易所指定免費發放即時基本市場行情的網站 | |
- 經濟通
- 強化版MQ
- 強化版TQ
- 財曆
- Mobile
Web
